| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 02/09/1999 | CA2069638C Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands |
| 02/04/1999 | WO1999005319A2 Methods and compounds for analyzing nucleic acids by mass spectrometry |
| 02/04/1999 | WO1999005200A1 Process for the preparation of polyether phosphates |
| 02/04/1999 | WO1999005154A1 Compositions and metal complexes having ancillary ligands |
| 02/04/1999 | WO1999005150A1 Nucleotide analog composition and synthesis method |
| 02/04/1999 | WO1999005149A1 Triazoline-thion-phosphoric acid derivatives |
| 02/04/1999 | WO1999005148A1 Phosphonated agents and their antiangiogenic and antitumorigenic use |
| 02/04/1999 | WO1999005126A1 Perfluorovinyl ionic compounds and their use in conductive materials |
| 02/04/1999 | WO1999005100A1 Ionic compounds with delocalized anionic charge, their use as components of ionic conductors or catalyst |
| 02/04/1999 | WO1999005080A1 Preparation of fluorinated compounds |
| 02/04/1999 | WO1999004774A2 Nucleotide analog compositions |
| 02/04/1999 | DE19732805A1 Bis-chloro:phosphane production |
| 02/04/1999 | CA2297900A1 Phosphonic acid naphthylureas and their antiantiogenic and antitumorigenic use |
| 02/04/1999 | CA2297657A1 Compositions and metal complexes having ancillary ligands |
| 02/03/1999 | EP0894116A1 Oxidation-stabilised polyamide moulding materials |
| 02/03/1999 | EP0748325B1 Process for preparing [l]- or [d]-homoalanin-4-yl-(methyl)phosphinic acid and its salts by racemic resolution |
| 02/03/1999 | CN1207102A 5h,10h-imidazo[1,2-alpha] indeno [1,2-3] pyrazine-4-one derivatives preparation thereof, intermediates thereof and drugs containing same |
| 02/03/1999 | CN1207101A Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
| 02/03/1999 | CN1041935C Benzo [f] quinoxalindione derivative, their use in medicine |
| 02/03/1999 | CN1041930C [1,2,4] triazolo [4,3-1] quinoxaline derivatives, their preparation and use |
| 02/02/1999 | US5866720 Reacting triarylphosphine with an alkali metal in the presence of molecular hydrogen. |
| 02/02/1999 | US5866691 Lactam nucleic acids |
| 02/02/1999 | US5866557 Use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions |
| 02/02/1999 | US5866556 Pyridinylbisphosphonates for use as a therapeutical agent |
| 02/02/1999 | US5866548 Caged membrane-permeant inositol phosphates |
| 02/02/1999 | US5866389 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes |
| 02/02/1999 | US5866318 Administering to nerve cells apopototic stimulant; calibration |
| 02/02/1999 | US5866087 Calixarene derivatives, their preparation process and their use for extracting actinides and lanthanides |
| 02/02/1999 | US5866045 Water soluble tri-substituted 1,2-dioxetane compounds and assay compositions having increased storage stability |
| 02/02/1999 | CA2066430C Process for the preparation of methylenebisphosphonic acids |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003867A1 Method for producing bidentate monoalkyl metal complexes |
| 01/28/1999 | WO1999003849A1 Fluorescent dibenzazole derivatives and methods related thereto |
| 01/28/1999 | WO1999003847A1 Process of production of 4-substituted-3-halogeno-1,4-benzoxazepine derivative and salts thereof |
| 01/28/1999 | WO1999003822A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | WO1999003802A1 Catalysed fluorination of carbonyl compounds |
| 01/28/1999 | WO1999003479A1 Lipid-based immune modulator composition |
| 01/28/1999 | DE19739159C1 Preparation of oxazaphosphorine-2-amine(s) used as, and to prepare, cytostatics and immunosuppressants |
| 01/28/1999 | DE19732292A1 Halogenation of cyclopropyl-methyl ketone |
| 01/28/1999 | DE19732033A1 Triazolinthion-phosphorsäure-Derivate Triazolinethione-phosphoric acid derivatives |
| 01/28/1999 | DE19731577A1 Use of mixtures containing 1-hydroxy-1,1- di:phosphonic acid(s) |
| 01/28/1999 | DE19731572A1 Pigment formulation useful in ink giving brilliant, light-fast ink-jet print |
| 01/28/1999 | DE19729908C1 Dimethoate production |
| 01/28/1999 | CA2296310A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | CA2295690A1 Lipid-based immune modulator composition |
| 01/28/1999 | CA2295304A1 Fluorescent dibenzazole derivatives and methods related thereto |
| 01/27/1999 | EP0892806A1 Organo phosphorous compounds |
| 01/27/1999 | EP0892797A1 Inhibitors of farnesyl protein transferase |
| 01/27/1999 | EP0892789A1 Irreversible inhibitors of tyrosine kinases |
| 01/27/1999 | CN1206502A Heterolamellar photovoltaic films |
| 01/27/1999 | CN1206419A Phosphonic acid diester derivatives |
| 01/27/1999 | CN1206357A Process for preparation by hydrogenation of catalysts based on transition metal and phosphine |
| 01/27/1999 | CN1206011A Novel diphenylarsines |
| 01/26/1999 | US5864040 Heating a nitroaniline with a phosphonate and ether or paraformaldehyde, hydrogenating the product with a rhodium, platinum, or palladium catalyst, coupling, cyclizing; for treatment of nervous system disorders |
| 01/26/1999 | US5864032 Biotin derivative of an 2-(n,n-diisopropyl-o-nitrilopropyl-phosphoramidito),3-(3-aminopropyl) -glycerol; labels for synthetic oligonucleotides; hybridisation probes |
| 01/26/1999 | US5863947 Treating central nervous diseases such as neurological diseases, neurodegenerative diseases, and as antipsychotic, anticonvulsant, analgesic and antiemetic agents |
| 01/26/1999 | US5863933 Substituted benzimidazoles |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863536 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitor for the treatment of glutamate abnormalities and associated nervous tissue ischemia in a animal and for treatment of prostate disease |
| 01/26/1999 | US5863437 Method and device for the separation of a mixture |
| 01/26/1999 | CA1340357C Purification of stable water-soluble dioxetanes |
| 01/26/1999 | CA1340343C Protected biotin derivatives |
| 01/21/1999 | WO1999002539A1 Diphosphonic acid salts for the treatment of osteoporosis |
| 01/21/1999 | WO1999002538A1 Novel chelating ligands having a tripodal backbone |
| 01/21/1999 | WO1999002537A1 Novel polyamphoteric phosphate ester surfactants |
| 01/21/1999 | WO1999002531A1 Process for synthesizing carbapenem side chain intermediates |
| 01/21/1999 | WO1999002485A1 Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders |
| 01/21/1999 | WO1999002166A1 Use of colchinol derivatives as vascular damaging agents |
| 01/21/1999 | WO1999002153A1 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases |
| 01/21/1999 | DE19730867A1 Verfahren zur Herstellung von mit bidentaten Liganden chelatisierten Monoalkylmetallkomplexen Process for the preparation of chelated with bidentate ligands Monoalkylmetallkomplexen |
| 01/21/1999 | CA2303210A1 Salts of diphosphonic acids and amino-alcohols for the treatment of osteoporosis |
| 01/20/1999 | EP0891998A1 Graft polymers |
| 01/20/1999 | EP0891979A1 A crystalline form of monohydrate monosodium salt of the N,N-Dimethyl-3-amino-1-Hydroxypropan-1,1-Disphosphonic acid and the procedure for its preparation |
| 01/20/1999 | EP0891393A1 Asymmetric benzoxanthene dyes |
| 01/20/1999 | EP0891324A1 Catalyzed vapor-phase isomerization of nonconjugated 2-alkyl-3-monoalkenenitriles |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/19/1999 | US5861540 Substituted 1,1,1-triaryl-2,2,2-trifuoroethanes and processes for their synthesis |
| 01/19/1999 | US5861525 Reacting tri-organo phosphate esters and organic or inorganic cyanides yields alkyl or aryl cyanide phosphonate esters and/or salts which can then be catalytically hydrogenated to form aminoalkylphosphonates useful as herbicides |
| 01/19/1999 | US5861428 Alleviation of osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis bullosa, inflammation, osteopenias, tempero |
| 01/19/1999 | US5861427 Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 01/19/1999 | US5861390 Treatment of breast cancer |
| 01/19/1999 | US5861385 Drug intermediates for compounds that lower cholesterol or treat hyperlipoproteinemia formed by reduction of acid or ester compounds with hydroxy or ether groups |
| 01/19/1999 | US5861384 Suppression of rejection after transplants for organs orally in an amount in the range of about 5 to 2000 mg. |
| 01/19/1999 | US5861358 Effective against mono- and di-cotyledon weeds |
| 01/19/1999 | US5861140 Tripodal paramagnetic contrast agents for MR imaging |
| 01/19/1999 | US5861138 Ligands for MRI contrast agent |
| 01/19/1999 | CA2073096C Phospholipid composition |
| 01/14/1999 | WO1999001461A1 Production of alkali metal diarylphosphide and cycloalkyldiarylphosphines |
| 01/14/1999 | DE19824983A1 New L-ascorbic acid derivative |
| 01/14/1999 | DE19727437A1 Verbesserung der Strukturbestimmung von biologischen Aggregaten in der Röntgenkristallographie Improvement in the structure determination of biological aggregates in the X-ray crystallography |
| 01/14/1999 | CA2295947A1 Production of alkali metal diarylphosphide and cycloalkyldiarylphosphines |
| 01/13/1999 | EP0890176A1 Proton conductor in liquid form |
| 01/13/1999 | EP0889896A1 Synthesis of cycloalkyldiarylphosphines |
| 01/13/1999 | EP0889895A1 Synthesis of cycloalkyldiarylphosphines |
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 01/13/1999 | EP0889863A2 Surface modified carbonate materials |
| 01/13/1999 | EP0768997B1 Polyalkoxyl terpene derivatives and compositions containing same |
| 01/13/1999 | EP0627438B1 Methanediphosphonate derivative, process for producing the same, and pharmaceutical use thereof |
| 01/13/1999 | CN1041633C Novel 2-thiosubstituted carbapenems |
| 01/12/1999 | US5859290 To produce n-phosphonomethylglycine or derivatives |